Drug firm Alkem Laboratories Friday reported a 13.58 per cent rise in its consolidated net profit to Rs 205.45 crore for the quarter ended December 31, 2018.
The company had posted a net profit of Rs 180.87 crore for the corresponding period of the previous fiscal, Alkem Laboratories said in a filing to BSE.
Consolidated revenue from operations of the company stood at Rs 1,925.03 crore for the quarter under consideration as against Rs 1,741.19 crore for the same period a year ago.
The company's board has declared an interim dividend of Rs 8 per equity share of the face value of 2 each, Alkem Laboratories said.
Shares of the company were trading at Rs 1,893.50 per scrip on BSE, up 0.57 per cent from its previous close.
Disclaimer: No Business Standard Journalist was involved in creation of this content
